About the journal
Therapeutic Advances in Psychopharmacology is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 2045-1253 · 2045-1261
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,650 USD
- Articles in DOAJ
- 343
- Declared review time
- 10 weeks
- Declared peer-review model
- other
- Official website
- https://journals.sagepub.com/home/tpp
Index listings
- DOAJ · 2019-07-04
- Indexing
- DOAJ
- APC
- 2,650 USD
- Declared review time (DOAJ)
- 10 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
343
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
10weeks
Works in OpenAlex
632
Last recorded publication year
2026
h-index
61
i10-index
317
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2019-07-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 92%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101555693
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Treatment of Major Depression
- Treatment of Major Depression
- Treatment of Major Depression
- Bipolar Disorder and Treatment
- Bipolar Disorder and Treatment
Show all subjects (75)
- Bipolar Disorder and Treatment
- Tryptophan and brain disorders
- Tryptophan and brain disorders
- Electroconvulsive Therapy Studies
- Psychiatric care and mental health services
- Electroconvulsive Therapy Studies
- Electroconvulsive Therapy Studies
- Healthcare Decision-Making and Restraints
- Healthcare Decision-Making and Restraints
- Psychedelics and Drug Studies
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Neurotransmitter Receptor Influence on Behavior
- Psychedelics and Drug Studies
- Pharmaceutical Practices and Patient Outcomes
- Psychedelics and Drug Studies
- Mental Health Treatment and Access
- Mental Health and Psychiatry
- Medication Adherence and Compliance
- Mental Health and Psychiatry
- Pharmacogenetics and Drug Metabolism
- Tryptophan and brain disorders
- Mental Health and Psychiatry
- Forensic Toxicology and Drug Analysis
- Forensic Toxicology and Drug Analysis
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Pharmaceutical studies and practices
- Historical Psychiatry and Medical Practices
- Pharmaceutical Practices and Patient Outcomes
- Obsessive-Compulsive Spectrum Disorders
- Pharmaceutical Practices and Patient Outcomes
- Attention Deficit Hyperactivity Disorder
- Attention Deficit Hyperactivity Disorder
- Mental Health Treatment and Access
- Parkinson's Disease and Spinal Disorders
- Mental Health Treatment and Access
- Obsessive-Compulsive Spectrum Disorders
- Parkinson's Disease and Spinal Disorders
- Substance Abuse Treatment and Outcomes
- Pain Management and Placebo Effect
- Pharmacovigilance and Adverse Drug Reactions
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Pain Management and Placebo Effect
- Family Caregiving in Mental Illness
- Family Caregiving in Mental Illness
- Sleep and related disorders
- Epilepsy research and treatment
- Pharmacovigilance and Adverse Drug Reactions
- Epilepsy research and treatment
- Pharmacology and Obesity Treatment
- Parkinson's Disease Mechanisms and Treatments
- Pharmacovigilance and Adverse Drug Reactions
- Cardiac electrophysiology and arrhythmias
- Cardiac electrophysiology and arrhythmias
- Posttraumatic Stress Disorder Research
- Opioid Use Disorder Treatment
- Dementia and Cognitive Impairment Research
- Sleep and related disorders
- Medication Adherence and Compliance
- Forensic Toxicology and Drug Analysis
- Psychotherapy Techniques and Applications
- Medication Adherence and Compliance
- Maternal Mental Health During Pregnancy and Postpartum
- Stress Responses and Cortisol
- Stress Responses and Cortisol
- Maternal Mental Health During Pregnancy and Postpartum
Keywords (DOAJ)
- psychopharmacology
- mental health
- psychiatry
- mental disorders
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ